One-year resource utilisation, costs and quality of life in patients with acute respiratory distress syndrome (ARDS): secondary analysis of a randomised controlled trial.

Détails

ID Serval
serval:BIB_C8D38B73B213
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
One-year resource utilisation, costs and quality of life in patients with acute respiratory distress syndrome (ARDS): secondary analysis of a randomised controlled trial.
Périodique
Journal of intensive care
Auteur(s)
Marti J., Hall P., Hamilton P., Lamb S., McCabe C., Lall R., Darbyshire J., Young D., Hulme C.
ISSN
2052-0492 (Print)
ISSN-L
2052-0492
Statut éditorial
Publié
Date de publication
2016
Peer-reviewed
Oui
Volume
4
Pages
56
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
The long-term economic and quality-of-life outcomes of patients admitted to intensive care unit (ICU) with acute respiratory distress syndrome are not well understood. In this study, we investigate 1-year costs, survival and quality of life following ICU admission in patients who required mechanical ventilation for acute respiratory distress syndrome.
Economic analysis of data collected alongside a UK-based multi-centre randomised, controlled trial, aimed at comparing high-frequency oscillatory ventilation with conventional mechanical ventilation. The study included 795 critically ill patients admitted to ICU. Hospital costs were assessed using daily data. Post-hospital healthcare costs, patient out-of-pocket expenses, lost earnings of survivors and their carers and health-related quality of life were assessed using follow-up surveys.
The mean cost of initial ICU stay was £26,857 (95 % CI £25,222-£28,491), and the average daily cost in ICU was £1738 (CI £1667-£1810). Following hospital discharge, the average 1-year cost among survivors was £7523 (CI £5692-£9354). The mean societal cost at 1 year was £44,077 (£41,168-£46,985), and the total societal cost divided by the number of 1-year survivors was £90,206. Survivors reported significantly lower health-related quality of life than the age- and sex-matched reference population, and this difference was more marked in younger patients.
Given the high costs and low health-related quality of life identified, there is significant scope for further research aimed at improving care in this in-need patient group.
ISRCTN10416500.
Pubmed
Web of science
Open Access
Oui
Création de la notice
26/09/2019 8:34
Dernière modification de la notice
27/09/2019 6:26
Données d'usage